CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. - Wikidata - wikimedia - TriplyDB

CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.

CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.

http://www.wikidata.org/entity/Q40003028

about

Pancreatic cancer stem cell markers and exosomes - the incentive push CXCR4 in breast cancer: oncogenic role and therapeutic targeting Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.Recent advances in bone-targeted therapies of metastatic prostate cancer Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.The role of HER2 in cancer therapy and targeted drug delivery The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.RaftProt: mammalian lipid raft proteome database.CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges.Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy.Targeting polymer therapeutics to bone.E-cadherin is critical for collective sheet migration and is regulated by the chemokine CXCL12 protein during restitution.Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure.PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family Modulation of chemokine receptor activity through dimerization and crosstalk Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis Real time monitoring of membrane GPCR reconstitution by plasmon waveguide resonance: on the role of lipids.CXCR4-based imaging agents.The signaling pathway of stromal cell-derived factor-1 and its role in kidney diseases.Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.Tpl2 induces castration resistant prostate cancer progression and metastasis.Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells CXCL12/SDF-1α induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.PGE2 /EP4 Signaling Controls the Transfer of the Mammary Stem Cell State by Lipid Rafts in Extracellular Vesicles.

P2860

Q26741215-1733474A-01DF-4EB6-AA80-132985021791 Q26781915-B141C3BD-8345-4EB2-87C2-05CC13D65DBB Q28388722-36631E7B-E212-4378-8724-E13F82538281 Q28393898-73A401F7-AF26-4253-A2A2-A347C7146BEC Q30010172-85596148-3F5C-4196-AA9F-1E5138540366 Q33464680-5A40F1C1-599D-4DD7-BAFD-94FC0B809898 Q33559560-E373B6F8-82AC-4DB3-A6B1-116C1C33C71D Q33703763-D9125C7A-C126-4313-8446-7A0030FB1620 Q34031600-22DC5308-7F4C-4C43-87CE-1C18F4929B3E Q34054213-53365D4E-8B31-4C6A-BDAA-8B297B24C601 Q34203682-051AAC20-B1A1-4014-9E54-E0ABAC994FD3 Q34611859-9C2F9885-AED4-427F-8303-2863B666E87A Q35003674-450D09A4-58A5-451E-A68F-510396D4E409 Q35253880-52DED797-CA08-4183-B20F-20475441640D Q35562824-20844730-6078-4101-9AF7-BBFE11945574 Q35580309-98CDBD73-7016-43E3-9227-A991AB2AB573 Q35838821-314EEC83-A38E-410A-AEB9-FE6A2F8A93B0 Q35871506-73A25A93-917A-4143-8550-A3A1C85A731F Q35951743-60477CB9-7A62-4B2E-AE27-FE318FCAB477 Q36052540-4A818E5C-4CEC-4A6A-B755-4DECE429DB34 Q36876322-4D92CC0C-A02C-4509-9748-D6746E15D3B0 Q37078475-FE7C6062-A24A-4F3B-A084-BC1B4E1B7D80 Q37100737-388C630A-6C70-4A9F-ABB3-AAADE8151DCC Q37116576-0BB92683-26A4-4E47-AF34-2D506858E7A1 Q37225329-63376A64-0D74-46B1-A4DB-C0D13C899C1E Q37316604-0F230698-4D2C-4B31-BF0E-FEA7BE10A8C1 Q37355817-FB1E7B1C-DACA-4B80-8131-3C055813038E Q37390708-FCD331A0-C315-49A3-BF13-BBEA640483A5 Q37400201-C18F1C64-981A-4958-A637-C0667204F408 Q37951878-6AEEDCA8-EF95-4BE5-9DCA-6937C7A83E18 Q38168568-15B1E3A6-9DD3-481C-AFFF-2DC06F2F8A29 Q38808628-350CACC8-C7BF-4A57-BC64-019E77D3485C Q38951496-0C05D6BC-CBF4-481C-AD57-9EEDC14851FF Q39029582-94950FEE-B829-4F24-8AD6-C2B4481E0AE2 Q39402696-469C51EF-213B-4DC3-9C44-5ECA1E68D168 Q39690717-B8C3AA82-419D-42C5-9ADD-1C526B276996 Q41144896-11E94A84-5EB7-4E6B-AC17-9335F285ECC7 Q41889452-BF56E973-E33A-4AB6-A8C2-F00249A3FCD8 Q42314593-B32D61BA-5200-41E0-9771-3A75614F26E1 Q42497415-A2A243B7-0FD2-42C1-9C88-5B0EEC70AB25

P2860

CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.

http://www.wikidata.org/entity/Q40003028

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

CXCL12/CXCR4 transactivates HE ...... f metastatic deposits in bone.

@en

type

label

CXCL12/CXCR4 transactivates HE ...... f metastatic deposits in bone.

@en

prefLabel

CXCL12/CXCR4 transactivates HE ...... f metastatic deposits in bone.

@en

P1433

Q40003028-B7D7533D-E5B1-4D03-8D12-A6276F036DD9

P1476

Q40003028-76092F15-B1B3-433C-B166-6197CF13C732

P2093

Q40003028-328310C5-F57D-455E-8854-AE6BCD2CA777

Q40003028-47E63E14-22F2-49AF-8AAC-78DB9E779279

Q40003028-4E649C74-BE4C-459A-95D7-7AB1455CE6D0

Q40003028-7C32366B-925E-4664-84CA-CCF2536D4701

Q40003028-C5DA085B-8F0D-47DB-AC12-2B79983D7590

Q40003028-C7D7CE87-4DE8-4C5A-A1E8-B19ECDAF2833

P2860

Q40003028-0152A039-FECC-45C4-98C8-069A05D68CFD

Q40003028-05D44B74-3E16-48AB-8896-3DCCD177B37D

Q40003028-09A7B65C-D3AC-4989-A169-581E7ABB452D

Q40003028-0A263ECB-41E9-4636-9321-F65D6D28C00A

Q40003028-0DFC82BB-8835-48E9-856A-56C2F1FBF0BB

Q40003028-1F53ACEA-B2E3-4E83-8F41-1749323D28C5

Q40003028-2FBC5FBE-254B-4103-8C46-38800C6DF0F3

Q40003028-312CFE14-9FC6-4B8A-A9BF-1D302E8C9369

Q40003028-376F8D64-D378-45F8-A5DA-A6108F6F7530

Q40003028-3CAB3955-1472-40FD-9AE5-32024A652BC5

P304

Q40003028-B5CD752D-5D1F-42E2-90CC-1577C294E12B

P31

Q40003028-BAA12062-F62B-4825-B0CF-BCC48B290E7A

P356

Q40003028-843801D1-BDB2-4504-905D-38FD4CE6BEF1

P433

Q40003028-73865377-13B5-482C-829B-47AA1DF2FDEB

P478

Q40003028-D212F918-47C1-488E-8BD7-FFB219783DB1

P577

Q40003028-78CB99B3-F627-4FEA-812B-AEFF9F0A2DEA

P698

Q40003028-257C4CF4-7B11-4CCD-B4CF-BF1424EBBFC2

P932

Q40003028-8CFE4E10-5230-46CA-BAEC-EDA1DCDCE410

P356

1541-7786.MCR-07-0117

P1433

Molecular Cancer Research

P1476

CXCL12/CXCR4 transactivates HE ...... f metastatic deposits in bone.

@en

P2093

Aaron Sabbota

http://www.w3.org/2001/XMLSchema#string

Hamilto Yamamoto

http://www.w3.org/2001/XMLSchema#string

Michael L Cher

http://www.w3.org/2001/XMLSchema#string

R Daniel Bonfil

http://www.w3.org/2001/XMLSchema#string

Sreenivasa R Chinni

http://www.w3.org/2001/XMLSchema#string

Zhong Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers

Untangling the ErbB signalling network

Lipid rafts and signal transduction

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions

c-Src and cooperating partners in human cancer.

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

P304

446-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-07-0117

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18337451

http://www.w3.org/2001/XMLSchema#string

P932

3842603

http://www.w3.org/2001/XMLSchema#string